108 related articles for article (PubMed ID: 1612786)
1. Arrest in late G2 or prophase of cell cycle induced by 4,4-(1,2-ethanediyl) bis (1-isobutoxycarbonyloxymethyl 2, 6-piperazinedione) (MST-16) in cultured L1210 cells.
Liu YP; Araya S; Nakamura T
Int J Cancer; 1992 Jul; 51(5):792-7. PubMed ID: 1612786
[TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines.
Lu DY; Huang M; Xu CH; Yang WY; Hu CX; Lin LP; Tong LJ; Li MH; Lu W; Zhang XW; Ding J
BMC Pharmacol; 2005 Jun; 5():11. PubMed ID: 15963241
[TBL] [Abstract][Full Text] [Related]
3. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.
Narita T; Yaguchi S; Komatsu T; Takase M; Hoshino A; Inaba M; Tsukagoshi S
Cancer Chemother Pharmacol; 1990; 26(3):193-7. PubMed ID: 2357766
[TBL] [Abstract][Full Text] [Related]
5. Effects of a prospective antitumor agent, 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane diperchlorate, on cultured mammalian cells.
Traganos F; Darzynkiewicz Z; Bueti C; Melamed MR
Cancer Invest; 1984; 2(1):1-13. PubMed ID: 6584191
[TBL] [Abstract][Full Text] [Related]
6. Imidazoacridinones arrest cell-cycle progression in the G2 phase of L1210 cells.
Augustin E; Wheatley DN; Lamb J; Konopa J
Cancer Chemother Pharmacol; 1996; 38(1):39-44. PubMed ID: 8603450
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
[TBL] [Abstract][Full Text] [Related]
8. Phase II study: treatment of non-Hodgkin's lymphoma with an oral antitumor derivative of bis(2,6-dioxopiperazine).
Ohno R; Yamada K; Hirano M; Shirakawa S; Tanaka M; Oguri T; Kodera Y; Mitomo Y; Ikeda Y; Yokomaku S
J Natl Cancer Inst; 1992 Mar; 84(6):435-8. PubMed ID: 1538420
[TBL] [Abstract][Full Text] [Related]
9. Dioxopiperazine derivative potentiates antitumor effect of methylglyoxal bis(cyclopentylamidinohydrazone) on human and mouse leukemia cells.
Hibasami H; Tsukada T; Shirakawa S; Narita T; Inagaki M; Nakashima K
Anticancer Res; 1994; 14(2A):561-4. PubMed ID: 8017861
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
Chabot GG; Momparler RL
Leuk Res; 1986; 10(5):533-7. PubMed ID: 2423812
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activities and schedule dependence of orally administered MST-16, a novel derivative of bis(2,6-dioxopiperazine).
Narita T; Koide Y; Yaguchi S; Kimura S; Izumisawa Y; Takase M; Inaba M; Tsukagoshi S
Cancer Chemother Pharmacol; 1991; 28(4):235-40. PubMed ID: 1879040
[TBL] [Abstract][Full Text] [Related]
12. Quantitative description of morphologic changes effected by antileukemic agents in L1210 leukemia cells.
Iwasaki H; Liu YP; Nojyo Y; Ueda T; Nakamura T
Anticancer Res; 1995; 15(1):133-9. PubMed ID: 7733623
[TBL] [Abstract][Full Text] [Related]
13. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
Smith PJ; Souès S; Gottlieb T; Falk SJ; Watson JV; Osborne RJ; Bleehen NM
Br J Cancer; 1994 Nov; 70(5):914-21. PubMed ID: 7947097
[TBL] [Abstract][Full Text] [Related]
14. MST-16, a novel bis-dioxopiperazine anticancer agent, ameliorates doxorubicin-induced acute toxicity while maintaining antitumor efficacy.
Yoshida M; Maehara Y; Sugimachi K
Clin Cancer Res; 1999 Dec; 5(12):4295-300. PubMed ID: 10632373
[TBL] [Abstract][Full Text] [Related]
15. MST-16, a novel derivative of bis(2,6-dioxopiperazine), synergistically enhances the antitumor effects of anthracyclines.
Inutsuka S; Baba H; Maehara Y; Sugimachi K
Cancer Chemother Pharmacol; 1998; 42(3):194-200. PubMed ID: 9685054
[TBL] [Abstract][Full Text] [Related]
16. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway.
Woods CM; Zhu J; McQueney PA; Bollag D; Lazarides E
Mol Med; 1995 Jul; 1(5):506-26. PubMed ID: 8529117
[TBL] [Abstract][Full Text] [Related]
17. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. I. Cell kinetic and biologic effects in cultured L1210, human epidermoid No. 2, and adenocarcinoma 755 cells.
Wheeler GP; Bono VH; Bowdon BJ; Adamson DJ; Wallace R
Cancer Treat Rep; 1976 Sep; 60(9):1307-16. PubMed ID: 1035133
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
Bhuyan BK; Fraser TJ; Day KJ
Cancer Res; 1977 Apr; 37(4):1057-63. PubMed ID: 139202
[TBL] [Abstract][Full Text] [Related]
19. Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway.
Nam C; Doi K; Nakayama H
Histol Histopathol; 2010 Apr; 25(4):485-93. PubMed ID: 20183801
[TBL] [Abstract][Full Text] [Related]
20. [Cytokinetic effects of 1,2-bis(4-isobutoxycarbonyloxymethyl-3,5- dioxopiperazin-1-yl) ethane (MST-16) on leukemia L1210 cells in mice].
He H; Wang MY; Zhang TM
Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):369-73. PubMed ID: 3195349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
